<?xml version="1.0" encoding="UTF-8"?>
<ANNEX xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:fmx="http://opoce" xsi:noNamespaceSchemaLocation="http://formex.publications.europa.eu/schema/formex-05.55-20141201.xd"><BIB.INSTANCE><DOCUMENT.REF FILE="L_2016078EN.01006001.doc.xml"><COLL>L</COLL><NO.OJ>078</NO.OJ><YEAR>2016</YEAR><LG.OJ>EN</LG.OJ><PAGE.FIRST>60</PAGE.FIRST><PAGE.SEQ>1</PAGE.SEQ><VOLUME.REF>01</VOLUME.REF></DOCUMENT.REF><DATE ISO="20160314">20160314</DATE><LG.DOC>EN</LG.DOC><NO.SEQ>0011.0002</NO.SEQ><PAGE.FIRST>72</PAGE.FIRST><PAGE.SEQ>1</PAGE.SEQ><PAGE.LAST>73</PAGE.LAST><PAGE.TOTAL>2</PAGE.TOTAL></BIB.INSTANCE><TITLE><TI><P>ANNEX II</P></TI></TITLE><CONTENTS><GR.SEQ LEVEL="1"><TITLE><TI><P><HT TYPE="BOLD">Conditions for assessing an exemption from the large exposure limit, in accordance with Article 400(2)(d) of Regulation (EU) No 575/2013 and Article 9(4) of this Regulation</HT></P></TI></TITLE><NP><NO.P>1.</NO.P><TXT>Credit institutions must take the following criteria into account when assessing whether an exposure referred to in Article 400(2)(d) of Regulation (EU) No 575/2013 meets the conditions for an exemption from the large exposure limit, in accordance with Article 400(3) of Regulation (EU) No 575/2013.</TXT><P><LIST TYPE="alpha"><ITEM><NP><NO.P>(a)</NO.P><TXT>For the purpose of assessing whether the specific nature of the exposure, the regional or central body or the relationship between the credit institution and the regional or central body eliminate or reduce the risk of the exposure, as provided for in Article 400(3)(a) of Regulation (EU) No 575/2013, credit institutions must take into account whether:</TXT><P><LIST TYPE="roman"><ITEM><NP><NO.P>(i)</NO.P><TXT>there are any current or anticipated material practical or legal impediments that would hinder the timely repayment of the exposure by the counterparty to the credit institution, other than in the event of a recovery or resolution situation, when the restrictions outlined in the Directive 2014/59/EU are required to be implemented;</TXT></NP></ITEM><ITEM><NP><NO.P>(ii)</NO.P><TXT>the proposed exposures are in line with the credit institution's ordinary course of business and its business model or justified by the funding structure of the network;</TXT></NP></ITEM><ITEM><NP><NO.P>(iii)</NO.P><TXT>the process by which a decision is made to approve an exposure to the credit institution's central body, and the monitoring and review process applicable to such exposures, at individual level and at consolidated level, where relevant, are similar to those that are applied to third-party lending;</TXT></NP></ITEM><ITEM><NP><NO.P>(iv)</NO.P><TXT>the credit institution's risk management procedures, IT system and internal reporting enable it to continuously check and ensure that the large exposures to its regional or central body are compatible with its risk strategy.</TXT></NP></ITEM></LIST></P></NP></ITEM><ITEM><NP><NO.P>(b)</NO.P><TXT>For the purpose of assessing whether any remaining concentration risk can be addressed by other equally effective means such as the arrangements, processes and mechanisms provided for in Article 81 of Directive 2013/36/EU, as provided for in Article 400(3)(b) of Regulation (EU) No 575/2013, credit institutions must take into account whether:</TXT><P><LIST TYPE="roman"><ITEM><NP><NO.P>(i)</NO.P><TXT>the credit institution has robust processes, procedures and controls to ensure that use of the exemption would not result in concentration risk which is outside its risk strategy;</TXT></NP></ITEM><ITEM><NP><NO.P>(ii)</NO.P><TXT>the credit institution has formally considered the concentration risk arising from exposures to its regional or central body as part of its overall risk assessment framework;</TXT></NP></ITEM><ITEM><NP><NO.P>(iii)</NO.P><TXT>the credit institution has a risk control framework that adequately monitors the proposed exposures;</TXT></NP></ITEM><ITEM><NP><NO.P>(iv)</NO.P><TXT>the concentration risk arising has been or will be clearly identified in the credit institution's internal capital adequacy assessment process (ICAAP) and will be actively managed. The arrangements, processes and mechanisms to manage the concentration risk will be assessed in the supervisory review and evaluation process.</TXT></NP></ITEM></LIST></P></NP></ITEM></LIST></P></NP><NP><NO.P>2.</NO.P><TXT>In addition to the conditions set out in paragraph 1, credit institutions must take into account, for the purpose of assessing whether the regional or central body with which the credit institution is associated in a network is responsible for cash-clearing operations, as provided for in Article 400(2)(d) of Regulation (EU) No 575/2013, whether the by-laws or articles of association of the regional or central body explicitly contain such responsibilities, including, but not limited to the following:</TXT><P><LIST TYPE="alpha"><ITEM><NP><NO.P>(a)</NO.P><TXT>market funding for the whole network;</TXT></NP></ITEM><ITEM><NP><NO.P>(b)</NO.P><TXT>clearing liquidity within the network, within the scope of in Article 10 of Regulation (EU) No 575/2013;</TXT></NP></ITEM><ITEM><NP><NO.P>(c)</NO.P><TXT>providing liquidity to affiliated credit institutions;</TXT></NP></ITEM><ITEM><NP><NO.P>(d)</NO.P><TXT>absorbing excess liquidity of affiliated credit institutions.</TXT></NP></ITEM></LIST></P></NP><?PAGE NO="73"?><NP><NO.P>3.</NO.P><TXT>For the purposes of verifying whether the conditions specified in paragraph 1 and 2 are met, the European Central Bank may request credit institutions to submit the following documentation.</TXT><P><LIST TYPE="alpha"><ITEM><NP><NO.P>(a)</NO.P><TXT>A letter signed by the credit institution's legal representative, with approval from the management body, stating that the credit institution complies with all the conditions laid down in Article 400(2)(d) and Article 400(3) of Regulation (EU) No 575/2013 for an exemption to be granted.</TXT></NP></ITEM><ITEM><NP><NO.P>(b)</NO.P><TXT>A legal opinion, issued either by an external independent third party or by an internal legal department, and approved by the management body, demonstrating that there are no obstacles that would hinder the timely repayment of exposures by a regional or central body to the credit institution arising from either applicable regulations, including fiscal regulations, or binding agreements.</TXT></NP></ITEM><ITEM><NP><NO.P>(c)</NO.P><TXT>A statement signed by the legal representative and approved by the management body that:</TXT><P><LIST TYPE="roman"><ITEM><NP><NO.P>(i)</NO.P><TXT>there are no practical impediments to the timely repayment of exposures by a regional or central body to the credit institution;</TXT></NP></ITEM><ITEM><NP><NO.P>(ii)</NO.P><TXT>the regional or central body exposures are justified by the funding structure of the network;</TXT></NP></ITEM><ITEM><NP><NO.P>(iii)</NO.P><TXT>the process by which a decision is made to approve an exposure to a regional or central body and the monitoring and review process applicable to such exposures, at legal entity level and at consolidated level, are similar to those applied to third-party lending;</TXT></NP></ITEM><ITEM><NP><NO.P>(iv)</NO.P><TXT>the concentration risk arising from exposures to the regional or central body has been considered as part of the credit institution's overall risk assessment framework.</TXT></NP></ITEM></LIST></P></NP></ITEM><ITEM><NP><NO.P>(d)</NO.P><TXT>Documentation signed by the legal representative and approved by the management body attesting that the credit institution's risk evaluation, measurement and control procedures are the same as the regional or central body's and that the credit institution's risk management procedures, IT system and internal reporting enable the management body to continuously monitor the level of the large exposure and its compatibility with the credit institution's risk strategy at legal entity level and at consolidated level, where relevant, and with the principles of sound internal liquidity management within the network.</TXT></NP></ITEM><ITEM><NP><NO.P>(e)</NO.P><TXT>Documentation showing that the ICAAP clearly identifies the concentration risk arising from the large exposures to the regional or central body and that this is actively managed.</TXT></NP></ITEM><ITEM><NP><NO.P>(f)</NO.P><TXT>Documentation showing that the management of concentration risk is consistent with the network's recovery plan.</TXT></NP></ITEM></LIST></P></NP></GR.SEQ></CONTENTS></ANNEX>